HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Labeling: FDA "Sensitive" To UPC Code Issues, Agency's Bowen Says

This article was originally published in The Rose Sheet

Executive Summary

FDA is considering omitting the space needed for a properly sized Uniform Product Code symbol from the calculation of whether an OTC package is exempt from the type size requirements of the OTC labeling final rule, FDA ODE V Deputy Director Debra Bowen, MD, and Division of OTC Drugs Director Charles Ganley, MD, said at an OTC labeling "feedback" meeting in Rockville, Md. June 29.
Advertisement

Related Content

Small Packaging Modifications Allowed In OTC Labeling Reg
Small Packaging Modifications Allowed In OTC Labeling Reg
Advertisement
UsernamePublicRestriction

Register

RS006866

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel